Comparing patient satisfaction and bone changes with zirconia and titanium implants in dentures
Assessment of Patient Satisfaction and Crestal Bone Changes Around One-piece Zirconia and Titanium Implants in Mandibular Implant-Retained Overdenture: A Randomized Clinical Trial
This study is testing whether men aged 50 to 60 feel more satisfied and experience different bone changes with zirconia or titanium dental implants in their dentures.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 50 Years to 60 Years |
| Sex | Male |
| Sponsor | Ain Shams University Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06643975 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates the differences in patient satisfaction and crestal bone changes between one-piece zirconia and titanium dental implants used in mandibular overdentures for completely edentulous male patients aged 50 to 60. The study involves a randomized approach where participants will receive either type of implant and will be monitored for 12 months following the placement of the definitive prosthetic. The goal is to determine if there are significant differences in outcomes between the two implant materials.
Who should consider this trial
Good fit: Ideal candidates are male patients aged 50 to 60 with moderately developed mandibular residual ridges and sufficient bone height for implant placement.
Not a fit: Patients with systemic diseases affecting bone quality, poor oral hygiene, or those who smoke heavily may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved patient satisfaction and better bone health outcomes for individuals receiving dental implants.
How similar studies have performed: Previous studies have shown varying success with different implant materials, but this specific comparison of zirconia and titanium in this context is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Male patients * The age range of 50 to 60 years old (average of 55). * moderately developed mandibular residual ridges, covered with healthy mucosa, firmly attached to the underling bone and with average mucosal thickness (2-3) mm. * At least 12 mm of vertical bone height in the mandible allowing for placement of a 10 mm implant (2 mm safety distance to inferior alveolar nerve). * Patients were selected with Angle class-I maxillomandibular relationship with sufficient inter-arch space (13-15mm Exclusion Criteria: * Heavy smokers of more than 10 cigarettes a day * Poor oral hygiene. * Patients with temporomandibular joint disorders(TMD), * Patients suffered of xerostomia, * Patients exhibited Para-functional habits, or recent extractions were excluded. * Patients with systemic diseases that might affect bone quality or quantity, or retard healing of the surgical wounds were excluded. * Patients receiving intravenous forms of bisphosphonates. * Patients who have had radiation therapy to the head and neck region. * Patients with existing implants in the jaws * Patients with previous bone grafting in either the maxillary or mandibular jaws.
Where this trial is running
Cairo
- Faculty of Dentistry, Ain Shams University — Cairo, Egypt (Recruiting)
Study contacts
- Principal investigator: Mohammad Irakky, masters — Faculty of Dentistry, Benha University
- Study coordinator: Mohammad Irakky, masters
- Email: implanteeth@hotmail.com
- Phone: 00201111232777
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.